Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.99 | N/A | +11.86% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.99 | N/A | +11.86% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed confidence in the brand's resilience despite external pressures. They emphasized their commitment to navigating supply chain issues effectively.
Management highlighted strong demand for their products.
They noted ongoing challenges in supply chain logistics.
Focus remains on maintaining market share amid competition.
Prestige Consumer HE's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 4.96% increase. The management's cautious optimism suggests they are navigating challenges while maintaining confidence in their product demand. Investors may view the EPS beat as a sign of strength, even without revenue details.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
OTIS WORLDWIDE CORP
Jan 31, 2022